Belmont, MA, United States of America

Camil Sayegh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ucb Holdings, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camil Sayegh. Retrieved from https://idiyas.com/inventor/camil-sayegh-jg100l45

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Camil Sayegh: Innovator in Inflammatory Disease Treatment

Introduction

Camil Sayegh is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Camil Sayegh holds a patent titled "Inflammatory Disease Treatment with Complement Inhibitors." This patent represents a significant advancement in the treatment of inflammatory conditions, showcasing his dedication to improving patient outcomes.

Career Highlights

Sayegh is currently employed at UCB Holdings, Inc., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Camil has worked alongside talented colleagues, including Ramin Farzaneh-Far and Alonso Ricardo. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in medical treatments.

Conclusion

Camil Sayegh's work in the field of inflammatory disease treatment exemplifies the impact of innovation in healthcare. His patent and ongoing contributions at UCB Holdings, Inc. highlight his commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…